Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Kestra Medical Technologies, Ltd.
KMTS
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $1.5B
$26.98
▲ +2.66%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$13.25 - $30.00
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 72.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
3 reasons
- Integrated platform combining device, digital health, and patient support in single solution
- Proprietary wearable technology with intuitive design reducing patient burden
- Comprehensive data analytics enabling personalized patient monitoring and intervention
Bear Case
2 risks
- Low volatility (beta 0.5).
- Growth premium of 0.0x vs Medical Devices peers. Reasonable for this growth rate.
Growth
Strong growth ahead
Expanding addressable market for wearable cardiac monitoring devices
Value
Growth premium of 0.0x vs Medical Devices peers. Reasonable for this growth rate.
Momentum
Hot
+32.5% over 3m
Quality
Strong
Emerging growth company (59% revenue growth). Early stage with higher risk.
Dividend
None
No dividend
Smart-money signal
Who's buying KMTS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Apr 20, 2026
Earnings recap unavailable for this period.
EPS surprise · last 4Q
Q3 26
-$0.61
Q2 25
-$0.64
Q1 25
-$0.50
Q4 25
-$2.21
Next: Apr 20, 2026
Revenue trend · last 8Q
—
—
—
+82%
+71%
+52%
+53%
+63%
Q4 24
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
Q3 26
$10.1M
$12.8M
$14.7M
$15.1M
$17.2M
$19.4M
$22.6M
$24.6M
Margins · last 8Q
Gross
52.6%
Operating
-141.6%
Profit
-139.2%
Wall Street consensus
2 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: Goldman Sachs · Apr 9, 2026